BRPI0516569A - derivados de 1,2,4-triazolilaminoaril(heteroaril)sulfonamida - Google Patents
derivados de 1,2,4-triazolilaminoaril(heteroaril)sulfonamidaInfo
- Publication number
- BRPI0516569A BRPI0516569A BRPI0516569-5A BRPI0516569A BRPI0516569A BR PI0516569 A BRPI0516569 A BR PI0516569A BR PI0516569 A BRPI0516569 A BR PI0516569A BR PI0516569 A BRPI0516569 A BR PI0516569A
- Authority
- BR
- Brazil
- Prior art keywords
- heteroaryl
- sulfonamide derivatives
- triazoliaminoaryl
- triazolylaminoaryl
- sulfonamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/14—Nitrogen atoms
Abstract
DERIVADOS DE 1,2,4-TRIAZOLILAMINOARIL(HETEROARIL)SULFONAMIDA. Derivados de 1,2,4 triazoliaminoarila(heteroaril)sulfonamida de Fórmula (1), sais farmaceuticamente aceitáveis destes, processos para a preparação de derivados de 1,2,4 triazoliaminoarila(heteroaril)sulfonamida e composições farmacêuticas contendo os derivados de 1,2,4 triazoliaminoaril(heteroaril)sulfonamida são descritos: Fórmula (1) os derivados de 1,2,4 triazoliaminoarila(heteroaril)sulfonamida de Fórmula (1) possuem atividade inibidora de ciclo celular e são conseqüentemente úteis para sua atividade de proliferação anticelular (tal como anti-câncer).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61711904P | 2004-10-08 | 2004-10-08 | |
PCT/US2005/036396 WO2006042215A1 (en) | 2004-10-08 | 2005-10-06 | 1,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0516569A true BRPI0516569A (pt) | 2008-09-16 |
Family
ID=36148673
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0516569-5A BRPI0516569A (pt) | 2004-10-08 | 2005-10-06 | derivados de 1,2,4-triazolilaminoaril(heteroaril)sulfonamida |
Country Status (14)
Country | Link |
---|---|
US (2) | US7888380B2 (pt) |
EP (1) | EP1797049A4 (pt) |
JP (1) | JP2008515925A (pt) |
KR (1) | KR20070061907A (pt) |
CN (1) | CN101084200A (pt) |
AU (1) | AU2005295016A1 (pt) |
BR (1) | BRPI0516569A (pt) |
CA (1) | CA2583150A1 (pt) |
EA (1) | EA200700818A1 (pt) |
IL (1) | IL182314A0 (pt) |
MX (1) | MX2007004155A (pt) |
NO (1) | NO20072310L (pt) |
WO (1) | WO2006042215A1 (pt) |
ZA (1) | ZA200703680B (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2007004155A (es) * | 2004-10-08 | 2007-09-11 | Johnson & Johnson | Derivados de 1,2,4-triazoloaminoaril (heteroaril) sulfonamida. |
WO2008075152A1 (en) * | 2006-12-15 | 2008-06-26 | Pfizer Products Inc. | 1- [4- (sulfonyl) -phenyl] -5- (benzyl) -ih-i, 2, 4-triazol derivatives as inhibitors of carbonic anhydrase for treating glaucoma or ocular hypertension |
FR2953518B1 (fr) | 2009-12-03 | 2012-01-20 | Sanofi Aventis | Procede de preparation d'un derive de combretastatine |
WO2013169793A2 (en) * | 2012-05-09 | 2013-11-14 | Ipierian, Inc. | Methods and compositions for tdp-43 proteinopathies |
KR20240011574A (ko) | 2022-07-19 | 2024-01-26 | 김학규 | 하우스의 수로관 연결시스템 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5382674A (en) * | 1988-12-19 | 1995-01-17 | Dowelanco | Preparation of 5-amino-1,2,4-triazole-3-sulfonamides |
PE20000127A1 (es) | 1997-12-22 | 2000-03-14 | Novartis Ag | Derivado de bencenosulfonamida |
GB9918180D0 (en) | 1999-08-02 | 1999-10-06 | Smithkline Beecham Plc | Novel compositions |
BR0111697A (pt) * | 2000-06-16 | 2003-07-08 | Bayer Cropscience Ag | Processo para preparação de 5-amino-n-fenil-1,2,4-triazol-3sulfonamidas substituìdas |
DE10038020A1 (de) | 2000-06-16 | 2001-12-20 | Bayer Ag | Verfahren zur Herstellung von substituierten 5-Amino-N-phenyl-1,2.4-triazol-3-sulfonamiden |
US6720338B2 (en) * | 2000-09-20 | 2004-04-13 | Abbott Laboratories | N-acylsulfonamide apoptosis promoters |
HUP0303868A3 (en) | 2000-12-22 | 2008-03-28 | Ortho Mcneil Pharm Inc | Substituted triazole diamine derivatives as kinase inhibitors and their use for preparation of pharmaceutical compositions |
CA2483282C (en) * | 2002-05-03 | 2012-05-29 | Janssen Pharmaceutica N.V. | Polymeric microemulsions |
ES2378987T3 (es) * | 2002-08-06 | 2012-04-19 | Toray Industries, Inc. | Remedio o agente preventivo para una enfermedad renal y procedimiento para diagnosticar una enfermedad renal |
TWI335913B (en) | 2002-11-15 | 2011-01-11 | Vertex Pharma | Diaminotriazoles useful as inhibitors of protein kinases |
CA2555825A1 (en) * | 2004-02-11 | 2005-08-25 | Janssen Pharmaceutica N.V. | Process for the preparation of substituted triazole compounds |
MX2007004155A (es) * | 2004-10-08 | 2007-09-11 | Johnson & Johnson | Derivados de 1,2,4-triazoloaminoaril (heteroaril) sulfonamida. |
-
2005
- 2005-10-06 MX MX2007004155A patent/MX2007004155A/es unknown
- 2005-10-06 EA EA200700818A patent/EA200700818A1/ru unknown
- 2005-10-06 KR KR1020077009701A patent/KR20070061907A/ko not_active Application Discontinuation
- 2005-10-06 EP EP05809950A patent/EP1797049A4/en not_active Withdrawn
- 2005-10-06 CN CNA2005800415390A patent/CN101084200A/zh active Pending
- 2005-10-06 US US11/245,314 patent/US7888380B2/en not_active Expired - Fee Related
- 2005-10-06 BR BRPI0516569-5A patent/BRPI0516569A/pt not_active Application Discontinuation
- 2005-10-06 JP JP2007535886A patent/JP2008515925A/ja not_active Withdrawn
- 2005-10-06 CA CA002583150A patent/CA2583150A1/en not_active Abandoned
- 2005-10-06 AU AU2005295016A patent/AU2005295016A1/en not_active Abandoned
- 2005-10-06 WO PCT/US2005/036396 patent/WO2006042215A1/en active Application Filing
-
2007
- 2007-03-29 IL IL182314A patent/IL182314A0/en unknown
- 2007-05-04 NO NO20072310A patent/NO20072310L/no not_active Application Discontinuation
- 2007-05-07 ZA ZA200703680A patent/ZA200703680B/xx unknown
-
2010
- 2010-09-29 US US12/893,925 patent/US8299082B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
IL182314A0 (en) | 2007-07-24 |
WO2006042215A1 (en) | 2006-04-20 |
US7888380B2 (en) | 2011-02-15 |
CN101084200A (zh) | 2007-12-05 |
MX2007004155A (es) | 2007-09-11 |
EP1797049A1 (en) | 2007-06-20 |
CA2583150A1 (en) | 2006-04-20 |
JP2008515925A (ja) | 2008-05-15 |
ZA200703680B (en) | 2008-10-29 |
US20110077249A1 (en) | 2011-03-31 |
EA200700818A1 (ru) | 2007-08-31 |
US20060173020A1 (en) | 2006-08-03 |
US8299082B2 (en) | 2012-10-30 |
NO20072310L (no) | 2007-06-14 |
EP1797049A4 (en) | 2009-06-17 |
AU2005295016A1 (en) | 2006-04-20 |
KR20070061907A (ko) | 2007-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0308212A (pt) | Composto, composição farmacêutica, e, uso de um composto | |
NO20071504L (no) | Pyrimidinderivanter. | |
MY141794A (en) | Benzamide and heteroarene derivatives | |
TNSN07075A1 (en) | Pyrimidine derivatives | |
UY30183A1 (es) | Derivados de quinolina | |
BRPI0716171B8 (pt) | composto, composição farmacêutica e uso de um composto | |
BR122019010008B8 (pt) | derivados de pirimidina, seu uso, e composição e combinação farmacêuticas | |
SE0402735D0 (sv) | Novel compounds | |
TR200400859T4 (tr) | Yeni heterosiklik bileşikler, özellikle antibakteriyel preparatları. | |
NO20080186L (no) | Heterosykliske aspartylproteaseinhibitorer, fremstilling og anvendelse derav | |
UA94065C2 (en) | Dihydropseudoerythromycin derivatives | |
ATE450533T1 (de) | Carboxamidderivate | |
TW200732323A (en) | Organic compounds | |
SE0302192D0 (sv) | Novel compounds | |
NO20052683L (no) | Nye pyridopyrimidinonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
BR112012032234A2 (pt) | "derivados de heteroaril imidazolona como inibidores de jak". | |
EA200870545A1 (ru) | Новые гетероциклические соединения | |
SE0401762D0 (sv) | Novel compounds | |
BRPI0413094A (pt) | derivados de quinolina e seu uso em terapia | |
BRPI0413151A (pt) | derivados de amino propanol | |
BRPI0512986A (pt) | novos derivados de hidantoìna | |
BRPI0516569A (pt) | derivados de 1,2,4-triazolilaminoaril(heteroaril)sulfonamida | |
SE0301699D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
TW200624429A (en) | Novel cysteine protease inhibitors | |
NO20052491L (no) | Nye vitronektinresepotr antagonistderivater, fremgangsmate til deres fremstilling, anvendelse derav som legemidler og farmasoytiske sammensetninger som inneholder de samme |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |